African Stock Exchanges

NEIMETH - Neimeth International Pharma

Twitter · Facebook
NEIMETH share price on Nigerian Stock ExchangeNEIMETH share price on Nigerian Stock Exchange

Neimeth International Pharmaceuticals Plc is the resultant company from the management-buy-out of the 60% equity holding of Pfizer Inc. in Pfizer Products Plc. This management-buy-out took place in May 1997 when Pfizer Inc., in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc, the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.

Neimeth International Pharma is listed on the Nigerian Stock Exchange (NGX) since September 21st, 1979. Neimeth International Pharma is traded on the NGX under the ticker symbol “NEIMETH”. The International Securities Identification Number (ISIN) of NGX:NEIMETH is NGNEIMETH001. Neimeth International Pharma is currently the 79th most valuable stock on the NGX with a market capitalization of NGN 7.14 billion, which makes about 0.024% of the Nigerian Stock Exchange equity market.

NEIMETH1.67 ▪ 0.00
10 hours ago
Last Trading Results
Opening Price
Day’s Low Price
Day’s High Price
Traded Volume27,500
Number of Deals2
Gross Turnover42,500.00
Growth & Valuation
Earnings Per Share
Price/Earning Ratio
Dividend Per Share
Dividend Yield
Shares Outstanding4.27B
Market Capitalization7.14B
Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated

NEIMETH Stock Market Performance


The current share price of Neimeth International Pharma (NEIMETH) is NGN 1.67. NEIMETH closed its last trading day (Monday, June 5, 2023) at 1.67 NGN per share on the Nigerian Stock Exchange (NGX). Neimeth International Pharma began the year with a share price of 1.43 NGN and has since gained 16.8% on that price valuation, ranking it 64th on the NGX in terms of year-to-date performance. Shareholders can be optimistic about NEIMETH knowing the stock has accrued 20% over the past four-week period alone—30th best on NGX.

Neimeth International Pharma is the seventh most traded stock on the Nigerian Stock Exchange over the past three months (Mar 1 - Jun 5, 2023). NEIMETH has traded a total volume of 1.12 billion shares—in 597 deals—valued at NGN 1.65 billion over the period, with an average of 17.7 million traded shares per session. A volume high of 1.07 billion was achieved on March 20th, and a low of 100 on March 10th, for the same period. The table below details the last 10 trading days of activity of Neimeth International Pharma on the Nigerian Stock Exchange.


Profile of Neimeth International Pharmaceuticals Plc

Neimeth International Pharmaceuticals Plc operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry.

Factsheet of Neimeth International Pharmaceuticals Plc

Health Care
Pharmaceuticals & Biotechnology
Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun, Lagos, Nigeria
+234-903-254-3202, +234-815-949-1935

NEIMETH Industrial Market Competitors

Neimeth International Pharmaceuticals Plc, issuers of the NEIMETH stock on the Nigerian Stock Exchange, have six market competitors who are also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below presents an overview of their market standing.

Index of African Stock Exchanges:

  1. Botswana Stock Exchange
  2. BRVM Stock Exchange
  3. Ghana Stock Exchange
  4. Johannesburg Stock Exchange
  5. Lusaka Securities Exchange
  6. Malawi Stock Exchange
  7. Nairobi Securities Exchange
  8. Nigerian Stock Exchange
  9. Uganda Securities Exchange
  10. Zimbabwe Stock Exchange


  1. Ike-obi (formerly Obi) Ayobamchukwu AnselmIke-obi (formerly Obi) Ayobamchukwu Anselm
    Jun 10, 2022 04:19 GMT

    What may I do next to start receiving your dividend? I have not received any of your dividend declared since October,2020 when I bought shares of your company ( Neimeth) despite the fact that I have filled and submitted my e dividend mandate form through my bank (UBA Plc). My CSCS account no is 40256746. And my Clearing House Number is C2662780OB. Thanks.

    1. John BulusJohn Bulus
      Jun 24, 2022 07:42 GMT

      I also have not received any dividends. I submitted the e-dividend mandate form, but the registrars refused to respond.

  2. andrew sundayandrew sunday
    Apr 17, 2020 13:34 GMT

    Neimeth International Pharmaceuticals Plc recent address is Plot 16 Billings Way Oregun Industrial Estate, Oregun Lagos

  • Showing 1 - 2 of 2
NOTE: You are replying to 's comment. [Cancel]